|
WO2020264239A1
|
|
Methods of diagnosing and predicting chronic lung and bowel disease in pre-term infants
|
|
WO2020160244A1
|
|
Methods and compositions for il10 signaling antagonism
|
|
AU2019315577A1
|
|
Methods and compositions for alphavirus vaccine
|
|
US2021115007A1
|
|
Streptococcus mutans glucosyl transferase inhibitors for dental caries therapy
|
|
US2019248855A1
|
|
Modified cystic fibrosis transmembrane conductance regulator (cftr) polypeptides with increased stability and uses thereof
|
|
WO2016077365A1
|
|
Compositions and methods for inhibiting fibrosis
|
|
WO2016019225A1
|
|
In vitro tissue-engineered cartilage models for osteoarthritis drug testing
|
|
WO2015179646A1
|
|
Hinged microfracture awls
|
|
US2017082638A1
|
|
Methods and compositions for diagnosis and treatment of meningitis
|
|
WO2015153965A1
|
|
Protective helmets for disaster situations
|
|
WO2015130734A1
|
|
Two-factor authentication systems and methods
|
|
WO2015127438A1
|
|
Iga nephropathy biomarkers and uses thereof
|
|
WO2015106084A1
|
|
Compositions that inhibit and prevent the formation of dental caries and methods of using the same
|
|
WO2015081159A1
|
|
Composites comprising nanostructured diamond and metal boride films and methods for producing same
|
|
WO2015073906A2
|
|
Systems and methods for analyzing sports impacts
|
|
WO2015073893A1
|
|
Systems for testing protective helmets
|
|
WO2015070090A1
|
|
Treatment for memory associated disorders
|
|
US2014362879A1
|
|
Saturable absorbers for Q-switching of middle infrared laser cavaties
|
|
WO2015024000A2
|
|
Mitochondrially-targeted electrophilic compounds for cancer treatment
|
|
CA2921217A1
|
|
Systems and methods for supporting bollards
|
